H. Lundbeck A/S
Nov 8, 2017

Lundbeck increased operating profit (EBIT) with 126% and EPS by 182% in the first nine months of 2017

Attachment

Valby, Denmark, 2017-11-08 07:45 CET (GLOBE NEWSWIRE) --  

HIGHLIGHTS

 

In connection with the financial report, Lundbeck's CFO and interim CEO, Anders Götzsche said:

"Lundbeck continues the strong growth and we continue to see improvements in the company's profitability and we are on track to deliver the best ever financial result for the company. Lundbeck continues to focus on advancing the pipeline to bring innovative medications to patients worldwide."

DKK million 9M 2017  9M 2016 Growth
Reported Revenue 12,842 11,469 12%
Reported EBIT 3,476 1,541 126%
Reported EPS 10.50 3.73 182%
Reported EBIT margin 27.1% 13.4% -
       
Core Revenue* 12,842 11,469 12%
Core EBIT* 3,946 2,463 60%
Core EPS* 12.69 7.60 67%
Core EBIT margin* 30.7% 21.5% -

       *For definition of the measures "Core Revenue", "Core EBIT" and "Core EPS", see note 9 Core reporting